Brief: Protara Therapeutics Announces Trials In Progress Poster Presentation For Advanced-1 Trial In Nmibc At 2022 American Society Of Clinical Oncology Annual Meeting
May 26 (Reuters) - Protara Therapeutics Inc TARA.O :
* PROTARA THERAPEUTICS ANNOUNCES TRIALS IN PROGRESS POSTER
PRESENTATION FOR ADVANCED-1 TRIAL IN NMIBC AT 2022 AMERICAN
SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING
Source text for Eikon: ID:nGNX93Smq9
Further company coverage: TARA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses